1. Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;
2. Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD;
3. College of Public Health Biostatistics, University of Nebraska Medical Center, Omaha, NE;
4. Lymphoma and Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;
5. Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
6. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;
7. Department of Pathology, City of Hope National Medical Center, Duarte, CA;
8. Center for Human Genetics, University of Nebraska Medical Center, Omaha, NE;
9. Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;
10. Pathology, University of Würzburg, Würzburg, Germany;
11. Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
12. Hematopathology Unit, Hospital Clinic, Barcelona, Spain;
13. Department of Pathology, University of Arizona, Tucson, AZ;
14. Department of Pathology, University of Toronto, Toronto, ON, Canada;
15. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD;
16. Oregon Health Sciences Center, Portland, OR;
17. Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; and
18. Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD